153 related articles for article (PubMed ID: 31884304)
1. Vitamin D deficiency and thyroid autoantibody fluctuations in patients with Graves' disease - A mere coincidence or a real relationship?
Płazińska MT; Czarnywojtek A; Sawicka-Gutaj N; Zgorzalewicz-Stachowiak M; Czarnocka B; Gut P; Karlinska M; Fichna M; Stachowski A; Ruchała M; Krela-Kaźmierczak I; Królicki L
Adv Med Sci; 2020 Mar; 65(1):39-45. PubMed ID: 31884304
[TBL] [Abstract][Full Text] [Related]
2. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
Komaki T; Sakata S; Nakamura S; Matsuda M; Kojima N; Takuno H; Miura K
Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):627-39. PubMed ID: 2583311
[TBL] [Abstract][Full Text] [Related]
3. Critical Differences between Induced and Spontaneous Mouse Models of Graves' Disease with Implications for Antigen-Specific Immunotherapy in Humans.
Rapoport B; Banuelos B; Aliesky HA; Hartwig Trier N; McLachlan SM
J Immunol; 2016 Dec; 197(12):4560-4568. PubMed ID: 27913646
[TBL] [Abstract][Full Text] [Related]
4. A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.
McLachlan SM; Aliesky HA; Rapoport B
Thyroid; 2019 Aug; 29(8):1138-1146. PubMed ID: 31184281
[No Abstract] [Full Text] [Related]
5. Low Vitamin D Status is Associated with Increased Thyrotropin-Receptor Antibody Titer in Graves Disease.
Zhang H; Liang L; Xie Z
Endocr Pract; 2015 Mar; 21(3):258-63. PubMed ID: 25370319
[TBL] [Abstract][Full Text] [Related]
6. Induction of oral tolerance in human autoimmune thyroid disease.
Lee S; Scherberg N; DeGroot LJ
Thyroid; 1998 Mar; 8(3):229-34. PubMed ID: 9545109
[TBL] [Abstract][Full Text] [Related]
7. The role of serum C-reactive protein measured by high-sensitive method in thyroid disease.
Czarnywojtek A; Owecki M; Zgorzalewicz-Stachowiak M; Woliński K; Szczepanek-Parulska E; Budny B; Florek E; Waligórska-Stachura J; Miechowicz I; Bączyk M; Sawicka N; Dhir S; Ruchała M
Arch Immunol Ther Exp (Warsz); 2014 Dec; 62(6):501-9. PubMed ID: 24794233
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of thyroid peroxidase, thyroglobulin and thyrotropin receptor antibodies in a long-term follow-up of juvenile Graves disease.
Lavard L; Perrild H; Jacobsen BB; Høier-Madsen M; Bendinelli G; Vitti P
Autoimmunity; 2000 Oct; 32(3):167-72. PubMed ID: 11092696
[TBL] [Abstract][Full Text] [Related]
9. Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodies.
McLachlan SM; Bahn R; Rapoport B
Autoimmunity; 1992; 14(2):143-8. PubMed ID: 1363894
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles Bearing TSH Receptor Protein and a Tolerogenic Molecule Do Not Induce Immune Tolerance but Exacerbate Thyroid Autoimmunity in hTSHR/NOD.
McLachlan SM; Aliesky HA; Rapoport B
J Immunol; 2019 May; 202(9):2570-2577. PubMed ID: 30944161
[TBL] [Abstract][Full Text] [Related]
11. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S
Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of thyroid-stimulating hormone (TSH) receptor antibody production following painless thyroiditis.
Iitaka M; Morgenthaler NG; Momotani N; Nagata A; Ishikawa N; Ito K; Katayama S; Ito K
Clin Endocrinol (Oxf); 2004 Jan; 60(1):49-53. PubMed ID: 14678287
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment with betamethasone of patients with Graves' disease given radioiodine therapy: thyroid autoantibody responses and outcome of therapy.
Gamstedt A; Karlsson A
J Clin Endocrinol Metab; 1991 Jul; 73(1):125-31. PubMed ID: 2045463
[TBL] [Abstract][Full Text] [Related]
14. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
15. A unique mouse strain that develops spontaneous, iodine-accelerated, pathogenic antibodies to the human thyrotrophin receptor.
Rapoport B; Aliesky HA; Banuelos B; Chen CR; McLachlan SM
J Immunol; 2015 May; 194(9):4154-61. PubMed ID: 25825442
[TBL] [Abstract][Full Text] [Related]
16. Persistent remission of Graves` disease or evolution from Graves' disease to Hashimoto's thyroiditis in childhood - a report of 6 cases and clinical implications.
Smyczńyska J; Cyniak-Magierska A; Stasiak M; Karbownik-Lewińska M; Lewiński A
Neuro Endocrinol Lett; 2014; 35(5):335-41. PubMed ID: 25275265
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases.
Zhu Y; Portmann L; Dénéréaz N; Lemarchand-Béraud T
Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224
[TBL] [Abstract][Full Text] [Related]
18. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.
Glinoer D; de Nayer P; Bex M;
Eur J Endocrinol; 2001 May; 144(5):475-83. PubMed ID: 11331213
[TBL] [Abstract][Full Text] [Related]
19. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.
Kristensen B
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836805
[TBL] [Abstract][Full Text] [Related]
20. Correlation between thyroid volume and humoral thyroid autoimmunity after radioiodine therapy in Graves' disease.
Sawicka N; Sowiński J
Endokrynol Pol; 2012; 63(1):10-3. PubMed ID: 22378091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
